In UKBB, SPRED1 heterozygotes had a significantly increased cancer prevalence compared to controls (OR: 3.8; 95% CI: 2.48–8.64; p = 1.2×10−3; Figure 1). The gene discussed is SPRED1; the disease is cancer.